Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

286
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
286
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

156
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
156
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

199
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
199
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

102
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
102
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

350
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
350
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

103
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
103

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of bempedoic acid on cardiovascular events across the spectrum of kidney function, a CLEAR Outcomes trial secondary analysis.

American journal of preventive cardiology·2026
Same author

Advancing Hypertension Treatment in Obstructive Sleep Apnea.

European journal of preventive cardiology·2026
Same author

Bempedoic Acid and Venous Thromboembolism Risk Among Statin-Intolerant Patients: A Post Hoc Analysis of the CLEAR Outcomes Randomized Clinical Trial.

JAMA cardiology·2026
Same author

Venous Thromboembolism Risk Among Different Statins: A Retrospective Cohort Study.

The Canadian journal of cardiology·2026
Same author

Clonal hematopoiesis of indeterminate potential and heart disease: What every internist needs to know.

Cleveland Clinic journal of medicine·2026
Same author

Effect of bempedoic acid in the absence of background lipid-lowering therapy on LDL cholesterol, hsCRP, and cardiovascular outcomes, among statin-intolerant patients: a post-hoc analysis of the CLEAR Outcomes trial.

European journal of preventive cardiology·2026

Related Experiment Video

Updated: Oct 28, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.4K

Intersection Between Chronic Kidney Disease and Cardiovascular Disease.

Luke J Laffin1, George L Bakris2

  • 1Section of Preventive Cardiology and Rehabilitation, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA.

Current Cardiology Reports
|July 16, 2021
PubMed
Summary

Cardiovascular disease and chronic kidney disease share risk factors and mechanisms. Managing cardiovascular health in kidney patients is vital due to higher heart disease prevalence.

Keywords:
AtherosclerosisCardiovascular diseaseChronic kidney diseaseHeart failure

More Related Videos

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

21.2K
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.0K

Related Experiment Videos

Last Updated: Oct 28, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.4K
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

21.2K
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.0K

Area of Science:

  • Nephrology
  • Cardiology
  • Public Health

Background:

  • Global chronic kidney disease (CKD) incidence is rising.
  • Cardiovascular disease (CVD) incidence has plateaued after a period of decline.
  • Understanding the interplay between CKD and CVD is critical.

Purpose of the Study:

  • To review the shared risk factors and pathogenic mechanisms of CKD and CVD.
  • To discuss current cardiovascular treatment strategies for patients with CKD.
  • To focus on atherosclerotic cardiovascular disease and heart failure in the context of CKD.

Main Methods:

  • Literature review of shared risk factors and mechanisms.
  • Analysis of contemporary cardiovascular treatment considerations.
  • Focus on specific CVD manifestations (atherosclerotic CVD, heart failure) in CKD patients.

Main Results:

  • CKD and CVD share common risk factors and pathogenic pathways.
  • Patients with CKD have a higher likelihood of developing CVD than progressing to end-stage renal disease.
  • Contemporary treatments for atherosclerotic CVD and heart failure in CKD require specific considerations.

Conclusions:

  • The convergence of CKD and CVD necessitates integrated management approaches.
  • Addressing shared risk factors is key to mitigating cardiovascular risk in CKD patients.
  • Tailored cardiovascular therapies are essential for improving outcomes in individuals with chronic kidney disease.